In some cases, achieving our strategic goals and objectives may be impeded by factors that are beyond the control of the Department of Health and Human Services (HHS). For example, national or local economic conditions can influence whether we are successful in helping families on welfare become economically independent. In some cases, there may b
Many programs within the Department have goals, objectives, and target populations that appear similar. Likewise, many Department programs appear to duplicate or overlap programs in other Federal agencies. Many state, local, and private sector programs also have goals, objectives, and target populations in common with Department programs. Because
Among the most important resources for research are databases and registries of health experience. Some are highly specialized but not very large; some are broad and enormous. Some are maintained only for research; some are primarily maintained for administrative or other purposes but are available for research. They may be organized by illness (l
Just as varied as the types of health data, of course, are the types of individuals and organizations who hold or process the data. Data are processed by:
So many kinds of health data are collected that it would be distracting and soporific to do more here than take note of the major categories. But it is essential to recognize: (a) that great research power resides in a diversity of health data, and (b) that privacy issues surround many kinds of data beyond those in primary medical records. Healt
Several current changes in the context within which health data are collected and used must be recognized. First, the boundaries between classical medical care and "public health" are becoming ever less distinct. Over the past decades the rubric, "health," has been broadened to include many matters—from hyperactivity in children, to teenagers' n
Wrongful disclosure of confidential health data may occur either through carelessness— through gossip in a clinic, for instance, or lazy discarding of clinical records—or through deliberate transgression, either by someone associated with the data-holder or by an outsider.
The public are rightly concerned about the erosion of privacy of information about health, for at least the following reasons taken together.
Several important legislative events are focusing attention on the issues.
A new "Health Insurance Portability and Accountability Act," which became law in August 1996, established several provisions relating to confidentiality of medical records as they are handled in health insurance, billing and payment data, and the like. How these are worked out will have implications for how data are accessed and processed in healt
The Report identifies many problem areas. The following are four large groups of issues that, while not entirely new, are growing rapidly in scale and complexity, and must urgently be attended to: Secondary uses of data, and data linking Research on private-sector health data Cybersecurity Genetic privacy. Issue cluster: Secondary res
Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Critical Barrier 3: Limited and Uncertain Payment for Pharmacotherapy
Industry decision makers recognize the heavy reliance of the substance abuse market on federal, state, and local government reimbursement. The perception among the drug companies is that many cocaine addicts do not have private insurance and rely on federal and state government sources for treatment, and that only a portion of those individuals wi
Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Critical Barrier 3: Limited and Uncertain Payment for Treatment
Another critical market barrier is the uncertainty surrounding the reimbursement of cocaine abuse and addiction treatment. The pharmaceutical company respondents, as well as one from a VC firm, voiced their concern over the heavy reliance of the substance abuse market on federal and state government reimbursement. The perception among the drug com
Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Market Penetration, Price, and Annual Revenue
In order to demonstrate basic relationships between market penetration, price, and annual revenue, the following analysis poses three levels of market penetration and three price levels for a new cocaine medication. The market penetration levels are "doubling," "saturation," and "half entry," as follows.
European Union Restreint ECO 291 CODEC 92 Common Position (EC) No /95 Adopted by the Council on 20 February 1995 With a View to Adopting Directive 94/ /EC of the European Parliament and of the Council on the Protection of Individuals With Regard to the Processing of Personal Data And on the Free Movement of Such Data On the
HHS Strategic Goals and Objectives - FY 2001 . Objective 3.6 - Improve the Health Status of American Indians and Alaska Natives
How We Will Accomplish Our Objective We will improve the quality of and access to health services for American Indian and Alaska Native people by: ensuring a supply of qualified, culturally competent health professionals with adequate facilities, equipment, supplies, and training.
HHS Strategic Goals and Objectives - FY 2001 . Objective 3.5 - Enhance the Fiscal Integrity of HCFA Programs and Purchase the Best Value Health Care for Beneficiaries
How We Will Accomplish Our Objective We will use value-based purchasing for Medicare and Medicaid. Our strategy includes:
HHS Strategic Goals and Objectives - FY 2001 . Objective 3.4 - Protect and Improve the Health and Satisfaction of Beneficiaries in Medicare and Medicaid
How We Will Accomplish Our Objective We will promote the use of preventive services for our beneficiaries. Our efforts will focus on: